Coronavirus
AstraZeneca boss Soriot says do not rush needlessly into COVID-19 jab booster: Report
AstraZeneca Plc Chief Executive Pascal Soriot said booster COVID vaccine doses may not be needed for everyone in Britain and rushing into a nationwide rollout of third doses risks piling extra pressure on the National Health Service (NHS), the Telegraph reported on Tuesday.
“We need the weight of the clinical evidence gathered from real world use before we can make an informed decision on a third dose,” Soriot wrote in the newspaper.
For more coronavirus news, visit our dedicated page.
He further said that “mobilizing the NHS for a boosting program that is not needed would potentially add unnecessary burden on the NHS over the long winter months.”
For the latest headlines, follow our Google News channel online or via the app.
Read more:
Saudi Arabia lifts COVID-19 travel ban to, from UAE, South Africa starting Sept. 8
Saudi King Salman fires director of public security, orders investigation
Can SinoBIO booster shot after Sinovac vaccine yields strong antibody response: Study
Also Read
-
CanSinoBIO booster shot after Sinovac vaccine yields strong antibody response: Study
A Chinese study looking at mixing COVID-19 vaccines showed that receiving a booster shot of CanSino Biologics’ vaccine after one or two doses of ... Coronavirus -
Analysis: Are COVID-19 boosters needed? FDA vaccine advisers face thorny question
Advisers to the US Food and Drug Administration are expected to discuss two key questions when they meet on Sept. 17 to consider a COVID-19 vaccine ... Coronavirus -
Top US health officials plan narrower COVID-19 booster launch: Source
Top US health officials have told the White House they would not have enough data for a broad COVID-19 booster rollout as President Joe Biden had ... Coronavirus -
Israel’s COVID-19 adviser calls country to prepare for a fourth booster vaccine shot
Israel’s national coronavirus adviser has called for the country to begin making preparations to eventually administer fourth doses of the coronavirus ... Coronavirus
